Association of BMI, lipid-lowering medication, and age with prevalence of type 2 diabetes in adults with heterozygous familial hypercholesterolaemia: a worldwide cross-sectional study
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216224%3A14110%2F24%3A00138508" target="_blank" >RIV/00216224:14110/24:00138508 - isvavai.cz</a>
Result on the web
<a href="https://www.thelancet.com/journals/landia/article/PIIS2213-8587%2824%2900221-3/fulltext" target="_blank" >https://www.thelancet.com/journals/landia/article/PIIS2213-8587%2824%2900221-3/fulltext</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/S2213-8587(24)00221-3" target="_blank" >10.1016/S2213-8587(24)00221-3</a>
Alternative languages
Result language
angličtina
Original language name
Association of BMI, lipid-lowering medication, and age with prevalence of type 2 diabetes in adults with heterozygous familial hypercholesterolaemia: a worldwide cross-sectional study
Original language description
Background Statins are the cornerstone treatment for patients with heterozygous familial hypercholesterolaemia but research suggests it could increase the risk of type 2 diabetes in the general population. A low prevalence of type 2 diabetes was reported in some familial hypercholesterolaemia cohorts, raising the question of whether these patients are protected against type 2 diabetes. Obesity is a well known risk factor for the development of type 2 diabetes. We aimed to investigate the associations of known key determinants of type 2 diabetes with its prevalence in people with heterozygous familial hypercholesterolaemia.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30201 - Cardiac and Cardiovascular systems
Result continuities
Project
<a href="/en/project/LX22NPO5104" target="_blank" >LX22NPO5104: National Institute for Research of Metabolic and Cardiovascular Diseases</a><br>
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Others
Publication year
2024
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
LANCET DIABETES & ENDOCRINOLOGY
ISSN
2213-8587
e-ISSN
2213-8595
Volume of the periodical
12
Issue of the periodical within the volume
11
Country of publishing house
US - UNITED STATES
Number of pages
13
Pages from-to
811-823
UT code for WoS article
001381420900001
EID of the result in the Scopus database
2-s2.0-85207124416